Celltrion's Sales Jump 35% in Q2; Shares Rise 4%

Celltrion (KRX:068270) posted second-quarter sales of 1.3 trillion won, up 35% from 961.5 billion won a year earlier, according to a Friday filing with the Korea Exchange. The South Korean biopharmaceutical company's operating income jumped 77% year over year to 430 billion won from 242.5 billion won, the filing said. Shares of Celltrion rose nearly 4% in recent trade.